Hovione plans to operate a commercial-scale continuous manufacturing facility as part of an agreement with Vertex Pharmaceuticals. It will be installed in Hovione’s NJ location and is expected to be complete by the end of 2017 to support manufacturing of Vertex’s approved medicines.     With continuous manufacturing, raw materials used to produce oral medicines (tablets) are fed into a single, continuously running machine that includes real-time release testing and can create comme...